VRTX — Vertex Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $112.92bn
- $105.68bn
- $12.00bn
U.S. STOCKS ON THE MOVE-Shake Shack, Arrowhead Pharmaceuticals, Lockheed Martin
U.S. STOCKS ON THE MOVE-Alkermes, Ball Corp, NovaBridge
Citi sees momentum in US pharma and biotech into 2026, updates ratings on top picks
U.S. STOCKS ON THE MOVE-Snowflake, Hecla Mining, Newmont
U.S. STOCKS ON THE MOVE-Vertex, Nike, Intel
U.S. STOCKS ON THE MOVE-Vertex, Nike, Intel
Leerink Partners lifts Vertex price target on pipeline optimism
U.S. RESEARCH ROUNDUP-Incyte, ServiceNow, Spire Global
Vertex's gene therapy shows promise in younger children with blood disorders
CRISPR gene therapy slashes 'bad' cholesterol, triglycerides by half in small study
US FDA awards six more fast-track vouchers to speed drug reviews (updated)
US FDA awards six more fast-track vouchers to speed drug reviews (updated)
Brief: FDA Announces Six Additional Awardees Under The CNPV Pilot Program
Vertex beats quarterly estimates on cystic fibrosis demand, new drugs
Vertex Pharma Q3 revenue beats estimates on strong demand for cystic fibrosis therapies
Brief: Vertex Pharmaceuticals VERTEX PHARMACEUTICALS Q3 ADJUSTED EPS USD 4.8 VS. IBES ESTIMATE USD 4.56
Brief: Vertex Announces Progress In Povetacicept Development Program And Presentation Of New Data At American Society Of Nephrology Kidney Week
US. STOCKS ON THE MOVE-Vertex, IBM, Silver Miners
US. STOCKS ON THE MOVE-Vertex, IBM, silver miners